CoLucid Pharmaceuticals, Inc. 4
4 · CoLucid Pharmaceuticals, Inc. · Filed May 12, 2016
Insider Transaction Report
Form 4
PAPPAS ARTHUR M
Director10% Owner
Transactions
- Award
Stock Option (Right to Buy)
2016-05-10+8,897→ 8,897 totalExercise: $6.24Exp: 2026-05-10→ Common Stock (8,897 underlying)
Footnotes (1)
- [F1]Options fully vest immediately prior to the start of the Issuer's first annual meeting of stockholders following the date of grant.